Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Small Molecules Studied

HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10271-2 PD 98059 LSM-3394 4713
10029-2 GW-5074 LSM-1029 5034
10262-1 L-779450 LSM-4283 9950176
10096-2 ZM-447439 LSM-1096 9914412
10219-2 U-0126 LSM-42806 5637
10259-1 ICRF-193 LSM-4280 115150
10228-2 IKK16 LSM-2309 9549298
10268-1 Nutlin 3a LSM-6351 11433190
10267-1 NU6102 LSM-4287 4566
10255-1 GSK1838705A LSM-4276 25182616
10253-1 Glycyl-H-1152 LSM-4274
10273-1 Purvalanol A LSM-3118 456214
10266-1 NSC 663284 LSM-2042 379077
10501-1 2-deoxyglucose
2-deoxy-D-glucose; 2-Desoxy-D-glucose; 2-DG
9062
10502-1 Bromopyruvic acid
3-bromopyruvic acid; Bromopyruvate
70684
10237-1 5-DFUR
5-FdUR; Doxifluridine
LSM-6359 18343
10512-1 Methylglyoxal
Acetylformaldehyde; Pyruvaldehyde
880
10248-1 Doxorubicin
Adriamycin
LSM-4062 31703
10283-1 XRP44X
AG-G-87906
LSM-4298 10339779
10272-1 Pemetrexed
Alimta
LSM-6353 446556
10099-2 Nilotinib
AMN-107
LSM-1099 644241
10261-1 Ixabepilone
Azaepothilone B; Ixempra
LSM-43293 216344
10056-2 Selumetinib
AZD6244; Array142886
LSM-1056 10127622
10508-1 FTase Inhibitor I
B581
132887
10008-3 Sorafenib
BAY-439006
LSM-1008 216239